Conference Coverage

Dubious diagnosis: Is there a better way to define ‘prediabetes’?


 

AT IDF WORLD DIABETES CONGRESS 2022

Whom should we throw the kitchen sink at?

Some of this discussion, Dr. Kirkman said, “is really a philosophical one, especially when you consider that lifestyle intervention has benefits for almost everyone on many short- and long-term outcomes.”

“The question is probably whom we should ‘throw the kitchen sink at,’ who should get more scalable advice that might apply to everyone regardless of glycemic levels, and whether there’s some more intermediate group that needs more of a [National Diabetes Prevention Program] approach.”

Dr. Selvin’s group is now working on gathering data to inform development of a risk-based prediabetes definition. “We have a whole research effort in this area. I hope that with some really strong data on risk in prediabetes, that can help to solve the heterogeneity issue. I’m focused on bringing evidence to bear to change the guidelines.”

In the meantime, she told this news organization, “I think there are things we can do now to provide more guidance. I get a lot of feedback from people saying things like ‘my physician told me I have prediabetes but now I don’t’ or ‘I saw in my labs that my blood sugar is elevated but my doctor never said anything.’ That’s a communications issue where we can do a better job.”

The meeting was sponsored by the International Diabetes Federation.

Dr. Selvin is deputy editor of Diabetes Care and on the editorial board of Diabetologia. She receives funding from the NIH and the Foundation for the NIH, and royalties from UpToDate for sections related to screening, diagnosis, and laboratory testing for diabetes. Dr. Kirkman reports no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Has the time come for glucose monitors for people without diabetes?
Journal of Clinical Outcomes Management
Patients complain some obesity care startups offer pills, and not much else
Journal of Clinical Outcomes Management
Best Practice Implementation and Clinical Inertia
Journal of Clinical Outcomes Management
FDA approves first-ever agent to delay type 1 diabetes onset
Journal of Clinical Outcomes Management
Will ICER review aid bid for Medicare to pay for obesity drugs?
Journal of Clinical Outcomes Management
With type 1 diabetes delay possible, focus now on screening
Journal of Clinical Outcomes Management
The TikTok trend that triggered a diabetes drug shortage
Journal of Clinical Outcomes Management
Cold water immersion can have benefits
Journal of Clinical Outcomes Management
Cognitive behavioral therapy app lowers A1c in type 2 diabetes
Journal of Clinical Outcomes Management
Fitbit figures: More steps per day cut type 2 diabetes risk
Journal of Clinical Outcomes Management